Tags

Type your tag names separated by a space and hit enter

The autologous pubovaginal fascial sling: An update in 2019.
Low Urin Tract Symptoms. 2020 Jan; 12(1):2-7.LU

Abstract

The contemporary management of stress urinary incontinence (SUI) has seen renewed interest in the use of autologous fascia for the formation of a retropubic suburethral sling. Traditionally, it has been used in only the most severe of incontinence cases, such as those women with intrinsic sphincter deficiency, or in patients requiring concomitant reconstructive procedures. In the current climate surrounding transvaginal mesh, many doctors and patients are shying away from the less morbid synthetic midurethral sling. International literature has demonstrated that the fascial sling is a safe and efficacious procedure for all patients with SUI, adequately treating both urethral hypermobility and intrinsic sphincter deficiency. This paper will discuss the indications, technique, and outcomes of autologous fascial slings. We will explore the use of fascial slings following failed synthetic slings and also the troubleshooting of commonly encountered issues intra- and postoperatively.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Plagakis S
Department of Surgery, Flinders Medical Centre, Adelaide, Australia.
Tse V
Department of Surgery, Concord Repatriation General Hospital, University of Sydney and Macquarie University, Sydney, Australia.

MeSH

FasciaFemaleHumansPatient SelectionSuburethral SlingsTransplantation, AutologousUrinary Incontinence, StressUrologic Surgical Procedures

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

31407861

Citation

Plagakis, Sophie, and Vincent Tse. "The Autologous Pubovaginal Fascial Sling: an Update in 2019." Lower Urinary Tract Symptoms, vol. 12, no. 1, 2020, pp. 2-7.
Plagakis S, Tse V. The autologous pubovaginal fascial sling: An update in 2019. Low Urin Tract Symptoms. 2020;12(1):2-7.
Plagakis, S., & Tse, V. (2020). The autologous pubovaginal fascial sling: An update in 2019. Lower Urinary Tract Symptoms, 12(1), 2-7. https://doi.org/10.1111/luts.12281
Plagakis S, Tse V. The Autologous Pubovaginal Fascial Sling: an Update in 2019. Low Urin Tract Symptoms. 2020;12(1):2-7. PubMed PMID: 31407861.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The autologous pubovaginal fascial sling: An update in 2019. AU - Plagakis,Sophie, AU - Tse,Vincent, Y1 - 2019/08/13/ PY - 2019/05/08/received PY - 2019/06/24/revised PY - 2019/07/02/accepted PY - 2019/8/14/pubmed PY - 2020/12/15/medline PY - 2019/8/14/entrez KW - autologous KW - detrusor underactivity KW - fascial KW - pubovaginal KW - sling KW - stress urinary incontinence SP - 2 EP - 7 JF - Lower urinary tract symptoms JO - Low Urin Tract Symptoms VL - 12 IS - 1 N2 - The contemporary management of stress urinary incontinence (SUI) has seen renewed interest in the use of autologous fascia for the formation of a retropubic suburethral sling. Traditionally, it has been used in only the most severe of incontinence cases, such as those women with intrinsic sphincter deficiency, or in patients requiring concomitant reconstructive procedures. In the current climate surrounding transvaginal mesh, many doctors and patients are shying away from the less morbid synthetic midurethral sling. International literature has demonstrated that the fascial sling is a safe and efficacious procedure for all patients with SUI, adequately treating both urethral hypermobility and intrinsic sphincter deficiency. This paper will discuss the indications, technique, and outcomes of autologous fascial slings. We will explore the use of fascial slings following failed synthetic slings and also the troubleshooting of commonly encountered issues intra- and postoperatively. SN - 1757-5672 UR - https://www.unboundmedicine.com/medline/citation/31407861/The_autologous_pubovaginal_fascial_sling:_An_update_in_2019_ DB - PRIME DP - Unbound Medicine ER -